News & Updates

Irritable bowel syndrome not a risk factor for Parkinson’s disease

04 Apr 2024

Individuals with irritable bowel syndrome (IBS) do not appear to be at increased risk of developing Parkinson’s disease compared with those who do not have IBS, according to the results of a Mendelian randomization analysis.

Irritable bowel syndrome not a risk factor for Parkinson’s disease

04 Apr 2024

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

02 Apr 2024 by

Researchers from a joint team at the University of Hong Kong (HKU) and Chinese Academy of Sciences have developed a novel neutralizing monoclonal antibody (mAb; 6H2) that targets circulating adipocyte fatty acid–binding protein (A-FABP), offering potential in alleviating cerebral ischaemic injury.

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

02 Apr 2024

Prenatal topiramate not associated with autism in offspring

02 Apr 2024 by

Prenatal exposure to topiramate does not increase the risk of autism in offspring, a US nationwide cohort study has shown.

Prenatal topiramate not associated with autism in offspring

02 Apr 2024

Edoxaban matches apixaban for stroke prevention in very elderly population

01 Apr 2024

Very elderly patients with nonvalvular atrial fibrillation fare well with either edoxaban or apixaban in terms of stroke prevention, although those on edoxaban may have higher bleeding risk, according to a study.

Edoxaban matches apixaban for stroke prevention in very elderly population

01 Apr 2024

Levodopa helps with gait problems in Dravet syndrome

25 Mar 2024

In patients with Dravet syndrome, treatment with levodopa appears to produce improvements in gait disturbance, as shown in a randomized crossover trial.

Levodopa helps with gait problems in Dravet syndrome

25 Mar 2024

Older patients with focal structural epilepsy at risk of postictal dysphagia

20 Mar 2024

Older patients with focal structural epilepsy are more likely to experience swallowing problems after seizures, according to a study.

Older patients with focal structural epilepsy at risk of postictal dysphagia

20 Mar 2024

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024 by

Mirtazapine, biperiden, and vitamin B6 are all beneficial in the treatment of antipsychotic-induced akathisia (AIA), with vitamin B6 having the best efficacy and tolerability profile, according to the results of a meta-analysis.

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024

Bevacizumab + EGFR-TKI improves OS in EGFR-mutated NSCLC with leptomeningeal metastases

20 Mar 2024 by

Adding bevacizumab to an EGFR tyrosine kinase inhibitor (TKI) improves overall survival (OS) in adult patients with EGFR-mutated non-small-cell lung cancer (NSCLC) and leptomeningeal metastases (LMs), according to a single-centre, retrospective, real-world study in China. OS was, however, similar between patients on chemotherapy plus EGFR-TKI and those on EGFR-TKI monotherapy.

Bevacizumab + EGFR-TKI improves OS in EGFR-mutated NSCLC with leptomeningeal metastases

20 Mar 2024

$Timing of extremity fracture fixation does not affect functional outcomes in patients with TBI$

Timing of extremity fracture fixation does not affect functional outcomes in patients with TBI

14 Mar 2024

In patients with traumatic brain injury (TBI) who sustained extremity fractures, fracture fixation performed within 24 hours after TBI does not appear to result in worse functional outcomes as opposed to when performed beyond 24 hours, according to a study.

Timing of extremity fracture fixation does not affect functional outcomes in patients with TBI

14 Mar 2024

Portable device shows promise in diagnosing neurodegenerative diseases

12 Mar 2024 by

A portable, wireless graphene field-effect transistor (GFET) biosensor device that can spot viruses, proteins, and small molecules with single-molecule sensitivity and specificity may be useful in detecting biomarkers for Alzheimer’s (AD) and Parkinson’s (PD) diseases, as reported in a study.

Portable device shows promise in diagnosing neurodegenerative diseases

12 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Irritable bowel syndrome not a risk factor for Parkinson’s disease

Irritable bowel syndrome not a risk factor for Parkinson’s disease

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

Prenatal topiramate not associated with autism in offspring

Prenatal topiramate not associated with autism in offspring

Edoxaban matches apixaban for stroke prevention in very elderly population

Edoxaban matches apixaban for stroke prevention in very elderly population

Levodopa helps with gait problems in Dravet syndrome

Levodopa helps with gait problems in Dravet syndrome

Older patients with focal structural epilepsy at risk of postictal dysphagia

Older patients with focal structural epilepsy at risk of postictal dysphagia

Vitamin B6 best bet against antipsychotic-induced akathisia

Vitamin B6 best bet against antipsychotic-induced akathisia

Bevacizumab + EGFR-TKI improves OS in EGFR-mutated NSCLC with leptomeningeal metastases

Bevacizumab + EGFR-TKI improves OS in EGFR-mutated NSCLC with leptomeningeal metastases

Timing of extremity fracture fixation does not affect functional outcomes in patients with TBI

Timing of extremity fracture fixation does not affect functional outcomes in patients with TBI

Portable device shows promise in diagnosing neurodegenerative diseases

Portable device shows promise in diagnosing neurodegenerative diseases